Pancreatic Cancer Research

ResearcherZhejiang Chinese Medical UniversityActive in the last 2 years

Kaidi Chen

Matched on ORCID iD 0009-0001-8797-1373; OpenAlex author ID A5091499716. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: 3 papers · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Coixenolide Enhances Antitumor Immunity of Cytotoxic CD8+ T Cells by Inhibiting S100A8/A9-CD36 Axis in Obesity-Associated Pancreatic Adenocarcinoma. Co-author DOI 10.1002/advs.202515759↗
  2. Glutathione S-transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide-induced ferroptosis in pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.freeradbiomed.2025.06.053↗
  3. Corrections to: “The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super‐enhancer activity and the PI3K/AKT/mTOR signall… Co-author DOI 10.1002/ctm2.70158↗
  4. Albumin conjugation promotes arsenic trioxide transport through alkaline phosphatase-associated transcytosis in MUC4 wildtype pancreatic cancer cells. Co-author DOI 10.1016/j.ijbiomac.2023.128756↗
  5. Integration of caveolin-mediated cytosolic delivery and enzyme-responsive releasing of squalenoyl nanoparticles enhance the anti-cancer efficacy of chidamide i… First author DOI 10.1016/j.ijpharm.2024.124072↗
  6. The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic… Co-author DOI 10.1002/ctm2.1500↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mancang Gu · 6 shared papers, 2023–2026 · strength 1.22
  2. Yuwei Qi · 4 shared papers, 2024–2026 · strength 0.80
  3. Lei Huang · 3 shared papers, 2023–2026 · strength 0.65
  4. Rong Chen · 3 shared papers, 2024–2026 · strength 0.60
  5. Wei Shan Li · 3 shared papers, 2024–2025 · strength 0.58
  6. Junyan Chen · 3 shared papers, 2024–2025 · strength 0.58
  7. Yan Xia Shi · 2 shared papers, 2023–2024 · strength 0.42
  8. Guanghai Dai · 2 shared papers, 2023–2024 · strength 0.42
  9. Yan Zhang · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.